Sales and Marketing

Showing 15 posts of 11524 posts found.

Insider Interview: BGMA Director Warwick Smith disputes recent generic price increase claims

February 22, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Warwick Smith, bgma, generics

Warwick Smith, Director of the British Generic Manufacturer’s Association (BGMA), discusses the recent data suggesting generic drug prices in the …
roche__tree

Roche and Discuva extend agreement to develop target antimicrobials

February 22, 2017 Research and Development, Sales and Marketing Discuva, Roche

Discuva, a drug discovery company based in Cambridge, UK, has announced that its collaboration with Roche, first agreed in 2014, …
headshot_ryan

Nativis bolsters boardroom with new director

February 22, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Nativis

Nativis Inc., a clinical stage life science bio-electronic company, has announced the appointment of Dr Una Ryan to its board …
pharmafocus_march_cover

The March 2017 issue of Pharmafocus is now live!

February 22, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actelion, FDA, Johnson & Johnson, MSD, Roche, Trump, crispr, immunotherapy, opdivo

The latest edition of Pharmafocus is available to read online now! From breakthroughs in antibiotic resistance R&D to gene editing …

FDA Priority Review for Pfizer investigational leukaemia drug

February 22, 2017 Research and Development, Sales and Marketing EMA, FDA, Inotuzumab ozogamicin, Pfizer, priority review

Pfizer has announced that its leukaemia treatment inotuzumab ozogamicin has been accepted for Priority Review by the US Food and …

NICE provisionally rejects Ipsen’s kidney cancer drug Cabometyx

February 21, 2017 Manufacturing and Production, Sales and Marketing Cometriq, NICE, ipsen

NICE has announced draft guidance for Ipsen’s cancer drug Cabometyx (cabozantinib), revealing it does not recommend the drug for use on …
handshake

Amygdala acquires Gilead’s candidate for addiction treatment

February 20, 2017 Manufacturing and Production, Sales and Marketing Amygdala, Gilead

Amygdala Neurosciences, a biopharmaceutical company that develops and commercialises drugs for the treatment of addiction disorders, has agreed an acquisition …

BlackThorn Therapeutics bring in new CEO

February 20, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BlackThorn Therapeutics

BlackThorn Therapeutics, a biopharmaceutical company that works on developing treatments for neurobehavioral disorders, announced the appointment of Gregory Vontz to …
medication

Generic version of top-selling lung cancer drug hits Chinese market

February 20, 2017 Sales and Marketing China, generics

A generic version of AstraZeneca’s Iressa (gefitinib) has been released onto the Chinese market, named Yiruike. The generic undercuts the …
celgene_1_02

Celgene’s potential blockbuster gets positive Phase 3 results in multiple sclerosis

February 20, 2017 Research and Development, Sales and Marketing Celgene, multiple sclerosis

Celgene’s drug to treat patients suffering with relapsing multiple sclerosis (RMS) was given a boost by positive Phase 3 trial …
heart_image

Cardiovascular disease expected to place $1 trillion cost burden on US

February 20, 2017 Medical Communications, Sales and Marketing cardiovascular disease

A study conducted by RTI International, a non-profit research institute, has warned that the US could have to balance over …
astrazeneca_logo_building

AstraZeneca sells off cancer drug to TerSera for $250 million

February 20, 2017 Sales and Marketing AstraZeneca, TerSera Therapeutics, Zoladex

AstraZeneca announced that it has sold Zoladex’s (goserelin acetate implant) commercial rights in the US and Canada to TerSera Therapeutics. …
hospital_ward

Rise of superbugs in hospitals down to cutting cleaners’ jobs, suggests GMB

February 20, 2017 Sales and Marketing GMB, MRSA, NHS, Superbugs

The rising numbers in those exposed to superbugs, such as E.coli and MRSA, is due to the cuts in the …
novartis_appointment

New Managing Director of UK & Ireland for Novartis

February 17, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis

Novartis announced the appointment of Haseeb Ahmad as Managing Director for UK & Ireland. He joins from MSD, known as …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

February 17, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

Stories have erupted out of the industry this week with leaps forward in malaria and cancer R&D, some controversial drug …
The Gateway to Local Adoption Series

Latest content